PROCÉDÉS D'ADMINISTRATION DE N-(5-TERT-BUTYL-ISOXAZOL-3-YL)-N'-{4-[7-(2-MORPHOLIN-4-YL-ÉTHOXY-)IMIDAZO-[2,1-B]-[1,3]-BENZOTHIAZOL-2-YL]PHÉNYL}URÉE POUR TRAITER UNE MALADIE PROLIFÉRATIVE
Provided herein are methods of administering N -(5- tert -butyl-isoxazol-3-yl)- N '-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, or a pharmaceutically acceptable salt or solvate thereof, to human patients. Specifically, dosing, dosing schedules or dosing regimens are provided herein. Further, pharmaceutical formulations are provided. Methods of treating proliferative diseases or FLT-3 mediated diseases in humans are also provided.